TY - JOUR
T1 - The potential role of epigenetic modulations in BPPV maneuver exercises
AU - Tsai, Kun Ling
AU - Wang, Chia To
AU - Kuo, Chia Hua
AU - Cheng, Yuan Yang
AU - Ma, Hsin I.
AU - Hung, Ching Hsia
AU - Tsai, Yi Ju
AU - Kao, Chung Lan
N1 - Funding Information:
This study was funded by NSC-96-2314-B-075-056-MY3, 100-2627-B-075-002-, 101-2627-B-075-001-, MOST 102-2314-B-010-061-MY3, from the Ministry of Science and Technology; MOST (former National Science Council; NSC); V104C-030, V105C-151 and DV102-10 from Taipei Veterans General Hospital-National Yang-Ming University Excellent Physician Scientists Cultivation Program, Taiwan.
PY - 2016
Y1 - 2016
N2 - Benign paroxysmal positional vertigo (BPPV) is one of the most common complaints encountered in clinics and is strongly correlated with advanced age or, possibly, degeneration. Redistribution exercises are the most effective approaches to treat BPPV, and canalith repositioning procedure (CRP) cure most BPPV cases. However, the mechanisms through which the treatment modulates systemic molecules in BPPV patients remain largely unknown. In this study, we report that the miR-34a and Sirtuin 1 (SIRT1) genes correlated with the treatment effects of CRP in BPPV subjects. We found that miR-34a expression was largely inhibited and SIRT1 expression was significantly reversed after BPPV maneuver treatment. We also confirmed that the PPAR-γ, PGC-1 and FoxO gene expressions were decreased immediately after canalith repositioning procedure (CRP) for BPPV, and were largely increased after a complete cure of BPPV. Moreover, we observed that after a complete recovery of BPPV, the ROS concentrations, pro-inflammatory cytokine concentrations and p53 expression levels were attenuated. We conclude that BPPV treatment might involve some epigenetic regulations through the mediation of miR-34a, SIRT1 functions and repression of redox status.
AB - Benign paroxysmal positional vertigo (BPPV) is one of the most common complaints encountered in clinics and is strongly correlated with advanced age or, possibly, degeneration. Redistribution exercises are the most effective approaches to treat BPPV, and canalith repositioning procedure (CRP) cure most BPPV cases. However, the mechanisms through which the treatment modulates systemic molecules in BPPV patients remain largely unknown. In this study, we report that the miR-34a and Sirtuin 1 (SIRT1) genes correlated with the treatment effects of CRP in BPPV subjects. We found that miR-34a expression was largely inhibited and SIRT1 expression was significantly reversed after BPPV maneuver treatment. We also confirmed that the PPAR-γ, PGC-1 and FoxO gene expressions were decreased immediately after canalith repositioning procedure (CRP) for BPPV, and were largely increased after a complete cure of BPPV. Moreover, we observed that after a complete recovery of BPPV, the ROS concentrations, pro-inflammatory cytokine concentrations and p53 expression levels were attenuated. We conclude that BPPV treatment might involve some epigenetic regulations through the mediation of miR-34a, SIRT1 functions and repression of redox status.
UR - http://www.scopus.com/inward/record.url?scp=84978132467&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84978132467&partnerID=8YFLogxK
U2 - 10.18632/oncotarget.9446
DO - 10.18632/oncotarget.9446
M3 - Article
C2 - 27203679
AN - SCOPUS:84978132467
SN - 1949-2553
VL - 7
SP - 35522
EP - 35534
JO - Oncotarget
JF - Oncotarget
IS - 24
ER -